Oxford Vaccine Against Covid-19 Starts Trials In São Paulo Healthcare Professionals

RIO DE JANEIRO, BRAZIL - The Federal University of São Paulo (UNIFESP) and the Lemann Foundation confirmed on Monday, June 22nd, that trials of the ChAdOx1 nCoV-19 vaccine, globally led by the University of Oxford in the United Kingdom, began in Subscribe to our Premium Membership Plan. Already Subscribed? Login Here